A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products

Conditions

• Rheumatoid Arthritis

Interventions

• BIOLOGICAL: Experimental: Arm A: DRL_RI
• BIOLOGICAL: Arm B: Rituxan®/Mabthera®

Sponsor

Dr. Reddy's Laboratories Limited

Collaborators

• [object Object]